Let's try this one more time.
Teresa, Dave, and Jenny, thank you very much for coming. I appreciate it. Thank you for having come before the committee before.
Dave, we've talked in times gone by. Since that conversation, I have learned that my children, who love to travel and have that travel bug.... My oldest son informed me that he was taking mefloquine—he did not tell me that until just the other day—and he was telling me how he stopped taking it because he started getting these weird dreams and nightmares. I'm so glad to hear him say that, obviously. I have an opportunity possibly to go to Pakistan in the next little while. When I was there as a child, the medication we had for malaria was different. Definitely, if they offer me mefloquine, it's not even an option as far as I'm concerned.
We know the impact it has had on your life. It's had a tremendous impact, and you have relayed that to us.
This discussion is about transition. We've heard from the ombudsman, basically saying we've studied this to death and nothing has come out of it. We've come up with all sorts of recommendations, and nothing has been done about them.
When we first started, I talked about taking a look at the transitions we've recommended, and whether they have actually been done.
Can you describe to us your transition as you relate from when you transitioned as much as you can.